BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6380290)

  • 1. Recombinant alpha interferon in retreatment of two patients with pulmonary lymphoma. Dramatic responses with resolution of pulmonary complications.
    Stevenson HC; Ochs JJ; Halverson L; Oldham RK; Sherwin SA; Foon KA
    Am J Med; 1984 Aug; 77(2):355-8. PubMed ID: 6380290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I-II study of recombinant alpha-2 interferon against advanced leukemia and lymphoma in children.
    Ochs J; Abromowitch M; Rudnick S; Murphy SB
    J Clin Oncol; 1986 Jun; 4(6):883-7. PubMed ID: 3458876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon.
    Foon KA; Sherwin SA; Abrams PG; Longo DL; Fer MF; Stevenson HC; Ochs JJ; Bottino GC; Schoenberger CS; Zeffren J
    N Engl J Med; 1984 Nov; 311(18):1148-52. PubMed ID: 6482933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study.
    O'Connell MJ; Colgan JP; Oken MM; Ritts RE; Kay NE; Itri LM
    J Clin Oncol; 1986 Feb; 4(2):128-36. PubMed ID: 3511183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant interferon-alpha-2C in laryngeal papillomatosis: preliminary results of a prospective multicentre trial.
    Zenner HP; Kley W; Clarós P; Clarós A; Labas Z; Löbe LP; Pavelka R; Plath P; Ribari O; Niethammer D
    Oncology; 1985; 42 Suppl 1():15-8. PubMed ID: 3909032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute respiratory distress syndrome after percutaneous cryotherapy for a pulmonary metastatic lesion.
    Tasaka S; Tomomatsu K; Funatsu Y; Soejima K; Ishizaka A
    Intern Med; 2010; 49(5):431-3. PubMed ID: 20190478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of recombinant alpha interferon in the treatment of advanced non-small cell lung carcinoma.
    Grunberg SM; Kempf RA; Itri LM; Venturi CL; Boswell WD; Mitchell MS
    Cancer Treat Rep; 1985 Sep; 69(9):1031-2. PubMed ID: 4028036
    [No Abstract]   [Full Text] [Related]  

  • 8. Alpha-2 interferon therapy for cutaneous T cell lymphoma.
    Tulli A
    J Am Acad Dermatol; 1989 Apr; 20(4):686-7. PubMed ID: 2785538
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant leukocyte A interferon in advanced breast cancer. Results of a phase II efficacy trial.
    Sherwin SA; Mayer D; Ochs JJ; Abrams PG; Knost JA; Foon KA; Fein S; Oldham RK
    Ann Intern Med; 1983 May; 98(5 Pt 1):598-602. PubMed ID: 6342490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal cell carcinoma: antitumor effects of leukocyte interferon.
    Quesada JR; Swanson DA; Trindade A; Gutterman JU
    Cancer Res; 1983 Feb; 43(2):940-7. PubMed ID: 6336662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a.
    White CW; Sondheimer HM; Crouch EC; Wilson H; Fan LL
    N Engl J Med; 1989 May; 320(18):1197-200. PubMed ID: 2710192
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
    Keeffe EB; Hollinger FB
    Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary pulmonary lymphoma--clinical review from a single institution in Singapore.
    Toh HC; Ang PT
    Leuk Lymphoma; 1997 Sep; 27(1-2):153-63. PubMed ID: 9373207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging the lungs in patients treated for lymphoma.
    Vargas HA; Hampson FA; Babar JL; Shaw AS
    Clin Radiol; 2009 Nov; 64(11):1048-55. PubMed ID: 19822237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of recombinant interferon alfa-2a in the therapy of cutaneous T-cell lymphomas.
    Bunn PA; Ihde DC; Foon KA
    Cancer; 1986 Apr; 57(8 Suppl):1689-95. PubMed ID: 3485012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finally, a successful adjuvant therapy for high-risk melanoma.
    Balch CM; Buzaid AC
    J Clin Oncol; 1996 Jan; 14(1):1-3. PubMed ID: 8558183
    [No Abstract]   [Full Text] [Related]  

  • 17. Human interferon alpha in malignant lymphoma and Hodgkin's disease. Results of the American Cancer Society trial.
    Horning SJ; Merigan TC; Krown SE; Gutterman JU; Louie A; Gallagher J; McCravey J; Abramson J; Cabanillas F; Oettgen H
    Cancer; 1985 Sep; 56(6):1305-10. PubMed ID: 4027869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete remission following recombinant interferon alpha-2a in a patient with diffuse large B cell cutaneous lymphoma.
    Tourani JM; Leaute JB; Lessana-Leibowitch M; Andrieu JM
    Nouv Rev Fr Hematol (1978); 1989; 31(4):315-6. PubMed ID: 2691984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant alpha 2 interferon-related cardiomyopathy.
    Cohen MC; Huberman MS; Nesto RW
    Am J Med; 1988 Oct; 85(4):549-51. PubMed ID: 3177405
    [No Abstract]   [Full Text] [Related]  

  • 20. Remarkable responses of metastatic renal cell cancer in multiple organs treated with alpha-interferon.
    Takita T; Tanaka J; Murase T; Shimoji T; Mitsuya H
    J Urol; 1986 Nov; 136(5):1061-2. PubMed ID: 3773069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.